The Japan Tardive Dyskinesia Therapeutics Marketsize was valued at USD 24.3 USD Million in 2023 and is projected to reach USD 101.75 USD Million by 2032, exhibiting a CAGR of 22.7 % during the forecast period.
We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.